Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools
PARIS, May 20, 2025 /PRNewswire/ -- Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced today the 30-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneous coronary intervention (PCI) study in female patients with complex, calcified coronary artery disease. The favorable results confirm the results of earlier retrospective analyses demonstrating the benefits of coronary intravascular lithotripsy (IVL) in female patients. The results were presented in a late-breaking presentation at the annual EuroPCR meeting in Paris.
Women with coronary artery calcification (CAC) undergoing PCI are often underrepresented in clinical trials and have historically poorer outcomes than men, including increased risk of adverse clinical outcomes and high rates of procedural complications with other calcium modification treatments, such as rotational or orbital atherectomy.1,2
Investigators designed the EMPOWER CAD study to evaluate real-world outcomes in female patients with severely calcified coronary lesions treated with an IVL-first treatment strategy and confirm positive results from previous studies showing similar safety and effectiveness outcomes across both men and women. EMPOWER CAD is a pivotal study comprised of a series of firsts: Shockwave's first prospective, post-market study of IVL examining an all-comers female population with minimal exclusion criteria, the first study to encourage a Shockwave IVL-first PCI strategy for calcified coronary lesions, and the first study to follow-up with enrolled patients for three years following IVL therapy.
The study enrolled 399 participants across 45 sites spanning five countries in the European Union and United States. The study is led by co-principal investigators Margaret McEntegart, M.D., Ph.D., Director of the Complex PCI and CTO programs and Cardiac Catheterization Labs at Columbia University Medical Center/NewYork-Presbyterian Hospital and Alexandra Lansky, M.D., Professor of Medicine in the section of Cardiovascular Medicine and Director, Heart and Vascular Clinical Research Program, Yale University School of Medicine. The study's European lead is Nieves Gonzalo, M.D., Ph.D., consultant interventional cardiologist at Hospital Clinico San Carlos in Madrid, Spain.†
"Women are typically underdiagnosed, underrepresented and have underwhelming outcomes in coronary artery disease studies," said Dr. Lansky. "Our goal with the EMPOWER CAD study was to address this gap and determine whether Shockwave IVL should be considered as the front-line calcium modification approach in female patients with complex coronary artery disease. The results demonstrate the benefits of IVL use in this specific patient population and validate findings from previous studies."
The primary effectiveness endpoint of procedural success, defined as stent delivery with ≤30% residual stenosis for all treated target lesions without in-hospital target lesion failure (TLF), was 86.9% at 30 days. The primary safety endpoint, defined as TLF as a composite of cardiac death, myocardial infarction attributable to target vessel (TV-MI) or ischemia-driven target lesion revascularization (ID-TLR) within 30 days, was 12.1%. TLF was primary driven by the rate of periprocedural MI3 (10.6%); the majority of these periprocedural MIs were not associated with any clinical signs or symptoms. Cardiac death and ID-TLR rates were each 1.3%. Procedural complications were rare with only one patient (0.2%) having a serious angiographic complication when assessed at the end of the procedure. There were also clinically and statistically significant improvements in health-related quality of life scores at 30 days compared to baselines.
"By leveraging a Shockwave IVL-first approach, the EMPOWER CAD 30-day results demonstrated high procedural success, low complication rates and significant improvements in quality of life among real-world female patients," said Dr. McEntegart. "While we look forward to following these patients for the next three years, these primary endpoint results confirm that excellent outcomes can be achieved with the use of Shockwave IVL in women with complex, calcified coronary artery disease."
Nick West., M.D., Chief Medical Officer, Shockwave Medical, emphasized the significance of the EMPOWER CAD study, stating, "Today marks a critical milestone in the journey to improve outcomes for female patients with calcified lesions. What began as an idea a few years ago is now a commendable reality today, thanks to study leadership and site investigators accelerating completion and reporting these important results. We're looking forward to learning more about the benefits of IVL therapy in this underrepresented patient population, both acutely and at extended follow-up."
About Shockwave MedicalShockwave Medical, Inc., part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
Cardiovascular Solutions from Johnson & Johnson MedTechAcross Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation, we are addressing conditions with significant unmet needs such as heart failure, coronary artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circulatory restoration and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke.
About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. Shockwave Medical, Inc. is part of Johnson & Johnson MedTech.
Cautions Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Shockwave Medical, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward healthcare cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither Shockwave Medical, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.as a result of new information or future events or developments.
† Drs. McEntegart, Lansky and Gonzalo are paid consultants of Shockwave Medical. They have not been compensated in connection with this press release.
1 Giustino et al., JACC Cardiovasc Int 2016; Ford et al., Catheter Cardiovasc Interv 2020; Hussain et al., JSCAI 2022.2 Kim et al. Catheter Cardiovasc Interv. 20163 As defined by SCAI for periprocedural MI and Fourth Universal (Type 4a) for spontaneous MI beyond discharge.
Media Contacts: Lindsey Diaz-MacInnisldiazmac@its.jnj.com
Rachael Jarnaginrjarnagi@its.jnj.com
Investor Contact:Sandra Easton Investor-relations@its.jnj.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shockwave-medical-study-confirms-benefit-of-ivl-first-strategy-in-real-world-female-patients-with-complex-calcified-lesions-in-late-breaking-data-presentation-at-europcr-2025-302459685.html
SOURCE Johnson & Johnson MedTech
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Nurse practitioners are treating older adults as ranks of geriatricians shrink
On Fridays, Stephanie Johnson has a busy schedule, driving her navy-blue Jeep from one patient's home to the next, seeing eight in all. Pregnant with her second child, she schleps a backpack instead of a traditional black bag to carry a laptop and essential medical supplies — stethoscope, blood pressure cuff and pulse oximeter. Forget a lunch break. She often eats a sandwich or some nuts as she heads to her next patient visit. On a gloomy Friday in January, Johnson, a nurse practitioner who treats older adults, had a hospice consult with Ellen, a patient in her 90s in declining health. To protect Ellen's identity, KFF Health News is not using her last name. 'Hello. How are you feeling?' Johnson asked as she entered Ellen's bedroom and inquired about her pain. The blinds were drawn. Ellen was in a wheelchair, wearing a white sweater, gray sweatpants and fuzzy socks. A headband was tied around her white hair. As usual, the TV was playing loudly in the background. 'It's fine, except this cough I've had since junior high,' Ellen said. Ellen had been diagnosed with vascular dementia, peripheral vascular disease, and Type 2 diabetes. Last fall, doctors made the difficult decision to operate on her foot. Before the surgery, Ellen was always colorful, wearing purple, yellow, blue, pink, and chunky necklaces. She enjoyed talking with the half-dozen other residents at her adult family home in Washington state. She had a hearty appetite that brought her to the breakfast table early. But lately, her enthusiasm for meals and socializing had waned. Johnson got down to eye level with Ellen to examine her, assessing her joints and range of motion, checking her blood pressure, and listening to her heart and lungs. Carefully, Johnson removed the bandage to examine Ellen's toes. Her lower legs were red but cold to the touch, which indicated her condition wasn't improving. Ellen's two younger sisters had power of attorney for her and made it clear that, above all, they wanted her to be comfortable. Now, Johnson thought it was time to have that difficult conversation with them about Ellen's prognosis, recommending her for hospice. 'Our patient isn't just the older adult,' Johnson said. 'It's also often the family member or the person helping to manage them.' Nurse practitioners are having those conversations more and more as their patient base trends older. They are increasingly filling a gap that is expected to widen as the senior population explodes and the number of geriatricians declines. The Health Resources and Services Administration projects a 50% increase in demand for geriatricians from 2018 to 2030, when the entire baby boom generation will be older than 65. By then, hundreds of geriatricians are expected to retire or leave the specialty, reducing their number to fewer than 7,600, with relatively few young doctors joining the field. That means many older adults will be relying on other primary care physicians, who already can't keep up with demand, and nurse practitioners, whose ranks are booming. The number of nurse practitioners specializing in geriatrics has more than tripled since 2010, increasing the availability of care to the current population of seniors, a recent study in JAMA Network Open found. According to a 2024 survey, of the roughly 431,000 licensed nurse practitioners, 15% are, like Johnson, certified to treat older adults. Johnson and her husband, Dustin, operate an NP-led private practice in greater Seattle, Washington, a state where she can practice independently. She and her team, which includes five additional nurse practitioners, each try to see about 10 patients a day, visiting each one every five to six weeks. Visits typically last 30 minutes to an hour, depending on the case. 'There are so many housebound older adults, and we're barely reaching them,' Johnson said. 'For those still in their private homes, there's such a huge need.' Laura Wagner, a professor of nursing and community health systems at the University of California-San Francisco, stressed that nurse practitioners are not trying to replace doctors; they're trying to meet patients' needs, wherever they may be. 'One of the things I'm most proud of is the role of nurse practitioners,' she said. 'We step into places where other providers may not, and geriatrics is a prime example of that.' Practice limits Nurse practitioners are registered nurses with advanced training that enables them to diagnose diseases, analyze diagnostic tests, and prescribe medicine. Their growth has bolstered primary care, and, like doctors, they can specialize in particular branches of medicine. Johnson, for example, has advanced training in gerontology. 'If we have a geriatrician shortage, then hiring more nurse practitioners trained in geriatrics is an ideal solution,' Wagner said, 'but there are a lot of barriers in place.' In 27 states and Washington, D.C., nurse practitioners can practice independently. But in the rest of the country, they need to have a collaborative agreement with or be under the supervision of another health care provider to provide care to older adults. Medicare generally reimburses for nurse practitioner services at 85% of the amount it pays physicians. Last year, in more than 40 states, the American Medical Association and its partners lobbied against what they see as 'scope creep' in the expanded roles of nurse practitioners and other health workers. The AMA points out that doctors must have more schooling and significantly more clinical experience than nurse practitioners. While the AMA says physician-led teams keep costs lower, a study published in 2020 in Health Services Research found similar patient outcomes and lower costs for nurse practitioner patients. Other studies, including one published in 2023 in the journal Medical Care Research and Review, have found health care models including nurse practitioners had better outcomes for patients with multiple chronic conditions than teams without an NP. Five states have granted NPs full practice authority since 2021, with Utah the most recent state to remove physician supervision requirements, in 2023. In March, however, Mississippi House Bill 849, which would have increased NP independence, failed. Meanwhile, 30 Texas physicians rallied to tamp down full-scope efforts in Austin. 'I would fully disagree that we're invading their scope of practice and shouldn't have full scope of our own,' Johnson said. She has worked under the supervision of physicians in Pennsylvania and Washington state but started seeing patients at her own practice in 2021. Like many nurse practitioners, she sees her patients in their homes. The first thing she does when she gets a new patient is manage their prescriptions, getting rid of unnecessary medications, especially those with harsh side effects. She works with the patient and a family member who often has power of attorney. She keeps them informed of subtle changes, such as whether a person was verbal and eating and whether their medical conditions have changed. While there is some overlap in expertise between geriatricians and nurse practitioners, there are areas where nurses typically excel, said Elizabeth White, an assistant professor of health services, policy, and practice at Brown University. 'We tend to be a little stronger in care coordination, family and patient education, and integrating care and social and medical needs. That's very much in the nursing domain,' she said. That care coordination will become even more critical as the U.S. ages. Today, about 18% of the U.S. population is 65 or over. In the next 30 years, the share of seniors is expected to reach 23%, as medical and technological advances enable people to live longer. Patient and family In an office next to Ellen's bedroom, Johnson called Ellen's younger sister Margaret Watt to recommend that Ellen enter hospice care. Johnson told her that Ellen had developed pneumonia and her body wasn't coping. Watt appreciated that Johnson had kept the family apprised of Ellen's condition for several years, saying she was a good communicator. 'She was accurate,' Watt said. 'What she said would happen, happened.' A month after the consult, Ellen died peacefully in her sleep. 'I do feel sadness,' Johnson said, 'but there's also a sense of relief that I've been with her through her suffering to try to alleviate it, and I've helped her meet her and her family's priorities in that time.' Jariel Arvin is a reporter with the Investigative Reporting Program at the University of California-Berkeley Graduate School of Journalism. He reported this article through a grant from The SCAN Foundation. KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.
Yahoo
12 hours ago
- Yahoo
Let's celebrate: Today is the summer solstice, the longest day of the year
Editor's note: This story was first published on June 21, 2013 Welcome to the best day of the year. Today is the summer solstice, the longest day. In North Jersey, we'll get more than 15 hours of daylight. Go ahead and gloat — that's nearly an hour and a half more daylight than Key West, Florida, will get today. For those who like daylight — pretty much everyone save Dracula — today is a day to celebrate. In past eras, they actually did. "The summer solstice was a carnivalesque feast day," said Pamela H. Smith, a European history expert at Columbia University. "In England, there were bonfires, lots of beer drinking, cannons being fired off, masqueraders — people dressed up as devils and demons. "Days like the solstice were important for ancient peoples in terms of trying to find patterns in nature that were important for their livelihood, like knowing when to plant crops. All cultures had megaliths like Stonehenge," Smith said. The Earth's orbit around the sun is slightly elliptical, but not enough to cause the seasons, said Carlton Pryor, an astronomer at Rutgers University. In fact, at the summer solstice, the North Jersey region is 94.4 million miles from the sun. At the winter solstice, it's only 91.4 million miles away. The seasons are caused by the Earth's axis being tilted at a 23.5 degree angle. When the Northern Hemisphere is tilted toward the sun, the hemisphere receives sunlight more directly, for longer periods, increasing temperatures. More: Make one of these 10 books that are set in New Jersey your next beach read for summer 2025 In winter, the Northern Hemisphere is tilted away — even though it is closer to the sun in miles — so the light is less direct, more angled. The sun is lower in the sky and appears for fewer hours, causing cooler temperatures. On the summer solstice, the Earth's northern axis is tilted at its most extreme angle toward the sun. Today in North Jersey, the sun at its zenith will be at an angle of nearly 73 degrees above the horizon. On Dec. 21, it will be only 26 degrees above the horizon. The Earth's axis tilt also affects where the sun rises on the horizon. Conventional wisdom that the sun rises in the east and sets in the west is true only twice a year — at the spring and fall equinoxes. During the summer solstice, the sun rises at its northernmost point on the horizon. This morning in Hackensack, if you had faced due east, the sun would have risen about 32 degrees to the north (or to your left). At the winter solstice, it will rise 32 degrees to the south of due east (or to your right). Though the summer solstice once triggered celebrations, that's rarely the case anymore. After the Protestant Reformation in Europe, religious leaders started to call for an end to the celebrations. "A lot of Protestant pastors criticized midsummer night's eve, saying people were drinking too much, fighting," Smith said. Another reason we don't celebrate the solstice is the shift from an agrarian lifestyle. "We live in a more urban society, and we have colonized the night," said Sara Schechner, an expert on science history at Harvard University. "So we are not as bound to the cycles of nature in how we go about our lives." This article originally appeared on Summer solstice 2025 is here
Hamilton Spectator
14 hours ago
- Hamilton Spectator
‘The biggest betrayal': A year on, staff grieve Ontario Science Centre's snap closure
TORONTO - In the year since the abrupt closure of the Ontario Science Centre, the cost of a new site at Ontario Place has escalated, its opening date has been pushed back, there is no sign of a temporary location – and the old building's roof that was said to be at risk of collapse appears to be intact. Workers say they've dealt with a rodent and raccoon infestation at a building where science centre materials are stored, and the department that builds exhibits is at a virtual standstill. It's been a year of demoralizing changes, they say. Government officials announced midday on June 21, 2024, that the science centre at its original, east Toronto location would permanently close at the end of the day, citing an engineering report on the state of the building's roof. Critics have blasted the decision, noting that the report presented several options other than full closure, and have suggested the whole plan to move the science centre to a revamped Ontario Place was designed to lessen the heat a more controversial tenant — a waterpark and spa by European company Therme — has generated. Infrastructure Minister Kinga Surma has said she did not want to jeopardize anyone's safety with the science centre's roof panels at risk of collapse. The workers do not buy it. Toronto set a weather record in 2024 with 1,145 millimetres of precipitation, which included two 'once-in-a-century' storms that flooded thousands of homes last summer and the city's snowiest winter in years. 'And the science centre is still standing,' said Raluca Ellis, the president of Local 549 of the Ontario Public Service Employees Union. 'It just seems like it was a manufactured crisis and that's the biggest betrayal.' NDP infrastructure critic Jennifer French also takes issue with stated reason for the closure. 'The roof managed to get through winter snow loads and a lot of rain this spring, and the only thing falling apart is the government's plan for a new science centre,' she said. The opening of the science centre at Ontario Place has already been pushed back from 2028 to 2029. A report from the auditor general late last year found that the cost estimate for building and maintaining the new science centre has increased by nearly $400 million from the government's spring 2023 business case for relocating it. Meanwhile, the government has said it will look for a space to house a temporary science centre until the new one opens. A request for proposals seeking a temporary location was released just days after the abrupt closure. It said the government was working 'expeditiously' to find an interim site and wanted it to open no later than Jan. 1, 2026. No such location has yet been announced, nearly one year later. Jason Ash, of the group Save Ontario's Science Centre, said it is a shame children are missing out. 'The bottom line, one year out from the closure of the science centre on Don Mills Road, is that a generation of Ontario kids and youth are without a world-class institution to learn about STEM (science, technology, engineering and mathematics) education,' he said. 'Regardless of any of the other aspects that enter into the story ... it's a real failure of the government's educational policy to have let down so many children.' The science centre is currently operating two pop-up exhibits at Harbourfront Centre and the CF Sherway Gardens mall in Toronto, and has had staff and small exhibits at various events around the city. The Ministry of Infrastructure said in a statement that it is working with the science centre to 'consider options' for a temporary location. As for the old building, the ministry said Infrastructure Ontario is managing it. 'IO has undertaken preventative measures to maintain integrity of the structure and roof since the facility was closed last year,' the ministry wrote. 'This includes managing snow load in the winter and rainwater and, mechanical repairs and system maintenance to ensure minimal heating and cooling levels.' As workers moved everything out of the old building last fall, one of the new storage locations presented a number of problems. All of the science centre's education materials were moved to a building by Highway 401 in Etobicoke. The building on Resources Road, which has become the science centre's official mailing address, is used as a warehouse of sorts where workers can gather experiments and small exhibits and other goodies for their visits to classrooms. That building had been vacant for more than a decade. Problems began immediately, said four employees with knowledge of what's been happening there. They asked not to be named for fear of repercussion. They said workers discovered mouse, and possibly rat, excrement throughout the basement and on the second floor of the building. And there were also signs of a raccoon infestation, they said. The workers found droppings and little hand prints that suggested a raccoon, or a family of raccoons, was living in the building. The building's manager laid out 'a ton' of rodent traps and one large raccoon trap after workers complained to science centre management, the sources said. There was no running water for a time, with very few power outlets and reams of extension cord snaking throughout the area, they added. Workers also discovered asbestos in the building. 'The entire ordeal moving to Resources Road has been very frustrating,' said one worker. 'The topper was the mouse and raccoon s—t.' The infestation was eventually fixed, the sources said, though it took months. The science centre declined requests for interviews with management, saying no one was available. It referred questions about the problems with the building to Infrastructure Ontario. The Ministry of Infrastructure statement said all pest control and maintenance issues were addressed promptly. 'Given the urgent requirement to find storage suitable for the Science Centre exhibits, artifacts and items in an extremely tight timeline, 101 Resources Road was identified as an available government-owned storage,' the ministry wrote. 'OSC continues to optimize operations, ensuring working conditions consistently meet all health and safety requirements.' The local union declined to discuss problems at the building. Ontario Science Centre CEO Paul Kortenaar pointed to ongoing pop-ups, special events and satellite locations for children to enjoy. 'Planning is underway for our new home at Ontario Place, with a competitive design process for our new flagship location on Toronto's waterfront,' Kortenaar said in a statement. Management is working on a 10-year master plan for the new science centre, he wrote. 'This work reflects our broader vision: we are reimagining what a science centre can be — not only a building, but a dynamic, provincewide platform for learning, discovery and connection.' The connection between management and workers has frayed since the closure. Working from home is not in the employees' DNA, said Ellis, the Local 549 president. 'We are not working in ideal conditions and many ask why we put up with this and the answer is because we love the science centre, but ever since we were shut down, we've lost that essence of what the science centre is,' she said. More than 20 union members have taken buyout packages over the past year, Ellis said, most due to the sudden change in job conditions. And the hope that workers could reunite in person at a new interim location was recently dashed. 'They told me the timeline for the interim location has been changed, that the process has paused and we don't know what the new timeline is,' Ellis said. For union steward Martin Fischer, who works in the education department, the loss of the original building has been 'heartbreaking.' 'It's been extremely difficult,' said Fischer, who describes himself and many colleagues as neurodivergent. 'I'm somebody who needs a physical workplace, I thrived in the environment at the science centre, being with classes a few hours a day, it could be kindergarten, it could be a high school class, it'd be adult and then I'd maybe go talk to the shops to help design and build stuff for the school program, but that's all gone now,' he said. He still goes to schools for presentations, but he also spends a lot of time at home in front of his computer. 'It's just not the same,' he said. Melis Tokgoz, vice president of the local union and an exhibit designer at the science centre, said she too has struggled since the closure. With the fabrication shop shuttered, there are far fewer designs to make, limited largely to the pop-up spots, she said. The science centre is looking at a few spots to restart designing and making exhibits for other science centres, but that work has largely stopped, Tokgoz said. 'We keep getting these reassurances that one day we'll be back in the business of designing exhibits, but again, it is really hard to build that trust when you have no evidence otherwise,' she said. That joie de vivre among employees is missing, she said. 'There's this sense of grief amongst many employees, missing what their jobs once were, missing the fulfilment, and I'm no different.' 'The energy has been sad and melancholic and a bit depressing the whole time.' This report by The Canadian Press was first published June 20, 2025.
